astrazeneca prevacid
Oct. 20, 2006 -- The FDA has approved the antipsychotic drug Seroquel to treat bipolar depression. Seroquel was already approved to treat the manic phases of bipolar disorder(formerly called manic-depressive illness). It had also been approved for the treatment of schizophrenia. The FDA's action makes Seroquel the first drug to treat both the depressive and manic phases of bipolar disorder, says Seroquel's maker, AstraZeneca, in a news release. The new approval applies to bipolar depression, not other forms of depression. The FDA decision was based on an eight-week study of 1,045 patients with bipolar depression, the drug company tells WebMD. Patients were randomly assigned to take Seroquel or a placebo containing no medicine. prevacid solutab dosage prevacid takes a few prevacid long prevacid vision prevacid in neonates